Laboratory Solutions was the largest of Avantor, Inc.’s 2 reported lines in fiscal 2025, at $8.80B — 67% of $13.10B.
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Laboratory Solutions | $10.00B | $9.48B | $9.22B | $8.80B | |||||
| Americas | — | — | — | — | |||||
| Europe | — | — | — | — | |||||
| Bioscience Production | $5.02B | $4.46B | $4.35B | $4.31B | |||||
| Amea | — | — | — | — | |||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
In fiscal 2025, which ended December 31, 2025, the 2 segments Avantor, Inc. reported in this breakdown added up to $13.10B. That was down 3.4% from $13.57B in fiscal 2024. Laboratory Solutions was the largest segment, at $8.80B or 67.1% of the total, followed by Bioscience Production ($4.31B, 32.9%).
Compared with fiscal 2024, every sizeable segment reported in both years shrank. Bioscience Production held up best, down 1.0% to $4.31B, while Laboratory Solutions fell the most, down 4.6% to $8.80B. Over fiscal 2022 to 2025, revenue across these segments went from $15.02B to $13.10B, a compound annual decline of 4.5%. Laboratory Solutions' share of the total rose from 66.6% to 67.1% over the same years.
The table also keeps 3 segments that Avantor, Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 3 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2017 to 2025, as reported in Avantor, Inc.'s annual filings.
Proprietary was the largest of Avantor, Inc.’s 2 reported lines in fiscal 2025, at $6.90B — 53% of $13.10B.
| Product and Service | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Proprietary | $8.05B | $7.44B | $7.23B | $6.90B | ||||
| Proprietary Materials Consumables | — | — | — | — | ||||
| Third-Party | $6.98B | $6.49B | $6.34B | $6.21B | ||||
| Third Party Materials Consumables | — | — | — | — | ||||
| Equipment Instrumentation | — | — | — | — | ||||
| Services Specialty Procurement | — | — | — | — | ||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines Avantor, Inc. reported in this breakdown added up to $13.10B. That was down 3.4% from $13.57B in fiscal 2024. Proprietary was the largest revenue line, at $6.90B or 52.6% of the total, followed by Third-Party ($6.21B, 47.4%).
Compared with fiscal 2024, every sizeable revenue line reported in both years shrank. Third-Party held up best, down 2.1% to $6.21B, while Proprietary fell the most, down 4.6% to $6.90B. Over fiscal 2022 to 2025, revenue across these revenue lines went from $15.02B to $13.10B, a compound annual decline of 4.5%. Proprietary's share of the total fell from 53.6% to 52.6% over the same years.
The table also keeps 4 revenue lines that Avantor, Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2018 to 2025, as reported in Avantor, Inc.'s annual filings.
United States was the largest of Avantor, Inc.’s 2 reported lines in fiscal 2025, at $6.56B — 50% of $13.10B.
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $8.56B | $7.41B | $7.10B | $6.56B | |||||
| All Other Countries | $6.47B | $6.52B | $6.47B | $6.55B | |||||
| Other Countries In Europe | — | — | — | — | |||||
| Germany | — | — | — | — | |||||
| Total | $15.02B | $13.93B | $13.57B | $13.10B |
In fiscal 2025, which ended December 31, 2025, the 2 regions Avantor, Inc. reported in this breakdown added up to $13.10B. That was down 3.4% from $13.57B in fiscal 2024. United States was the largest region, at $6.56B or 50.1% of the total, followed by All Other Countries ($6.55B, 49.9%).
Compared with fiscal 2024, All Other Countries grew the fastest, rising 1.2% to $6.55B. United States fell the most, down 7.6% to $6.56B. Over fiscal 2022 to 2025, revenue across these regions went from $15.02B to $13.10B, a compound annual decline of 4.5%. United States' share of the total fell from 56.9% to 50.1% over the same years.
The table also keeps 2 regions that Avantor, Inc. no longer reports, so earlier years can still be read on their original basis; use "Show 2 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2017 to 2025, as reported in Avantor, Inc.'s annual filings.
Avantor, Inc. (AVTR) breaks its revenue down by segment, revenue line and region. In fiscal 2025, its largest segment was Laboratory Solutions, with $8.80B or 67.1% of the total, followed by Bioscience Production at $4.31B (32.9%).
Laboratory Solutions was Avantor, Inc.'s largest segment in fiscal 2025, with $8.80B in revenue, 67.1% of the $13.10B reported across its 2 segments.
Proprietary was Avantor, Inc.'s largest revenue line in fiscal 2025, with $6.90B in revenue, 52.6% of the $13.10B reported across its 2 revenue lines.
United States was Avantor, Inc.'s largest region in fiscal 2025, with $6.56B in revenue, 50.1% of the $13.10B reported across its 2 regions.
Of the Avantor, Inc. regions reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, All Other Countries grew the fastest, rising 1.2% from $6.47B to $6.55B.
Every figure is taken from Avantor, Inc.'s annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2017 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.